Compare EVTC & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVTC | BHVN |
|---|---|---|
| Founded | 1988 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2013 | 2022 |
| Metric | EVTC | BHVN |
|---|---|---|
| Price | $31.38 | $14.41 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 14 |
| Target Price | ★ $35.80 | $29.08 |
| AVG Volume (30 Days) | 382.6K | ★ 1.8M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.67% | N/A |
| EPS Growth | ★ 27.17 | 26.08 |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $453,869,000.00 | N/A |
| Revenue This Year | $12.68 | N/A |
| Revenue Next Year | $6.86 | N/A |
| P/E Ratio | $64.70 | ★ N/A |
| Revenue Growth | ★ 11.48 | N/A |
| 52 Week Low | $21.81 | $7.48 |
| 52 Week High | $37.38 | $18.57 |
| Indicator | EVTC | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 58.40 | 51.98 |
| Support Level | $27.98 | $13.84 |
| Resistance Level | $34.41 | $17.01 |
| Average True Range (ATR) | 1.31 | 0.64 |
| MACD | -0.18 | 0.01 |
| Stochastic Oscillator | 46.43 | 72.50 |
Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions. Latin America Payments and Solutions segment derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.